We hope you are enjoying your membership to HealthCareMandA.com. This Health Care M&A Weekly chart below is a selection of transactions announced during the prior week(s). The deals presented here are further elaborated in the monthly newsletter, Health Care M&A News, and in the quarterly report.
This information also appears in our online database, Deal Search Online. Visit www.dealsearchonline.com to open a guest account and begin your search.
Biotechnology | ||
Acquirer | Target | Price |
Denali Therapeutics Inc. | F-star Gamma Ltd. | $24 million |
Zai Lab Limited | Exclusive worldwide license to protein therapeutics | N/A |
eHealth | ||
Acquirer | Target | Price |
ResMed Inc. | HEALTHCAREfirst | N/A |
Aquiline Capital Partners | Aspirion Health Resources | N/A |
Laboratories, MRI and Dialysis | ||
Acquirer | Target | Price |
Myriad Genetics, Inc. | Counsyl, Inc. | $375 million |
Managed Care | ||
Acquirer | Target | Price |
WellCare Health Plans, Inc.
|
Meridian | $2.5 billion |
Pharmaceuticals | ||
Acquirer | Target | Price |
Newsoara Biopharma Co., Ltd. | Exclusive rights to PDE4 inhibitor program in China | N/A |
Acerus Pharmaceuticals Corporation | Exclusive rights to SHACT | N/A |
Link Health Group LTD | Exclusive license to Lidoderm in China | N/A |
Physician Medical Groups | ||
Acquirer | Target | Price |
Revelstoke Capital Partners | Cincinnati Eye Institute | N/A |
Other | ||
Acquirer | Target | Price |
Linden Capital Partners | Evolution Research Group, LLC | N/A |